(Q37253012)

English

Febuxostat

scientific article published on January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

Febuxostat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Gillian M Keating

3

object named as

Gillian M Keating

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

author name string

Philip I Hair

1

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Paul L McCormack

2

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

1865-1874

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Pathogenesis of Gout

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200868130-00006

21 January 2018

Epidemiology of hyperuricemia and gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of acute and chronic gouty arthritis: present state-of-the-art

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of gout in older adults: barriers to optimal control

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro drug-drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical practice. Gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current management of gout in patients unresponsive or allergic to allopurinol

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Febuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of gout: is the incidence rising?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18729537

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200868130-00006

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37253012&oldid=2200088690"